StockGuru Spotlight on Cellceutix Corp.
(Symbol: CTIX)
Help us update information on this company. Email any updates to: [email protected]
About Cellceutix Corp.:
An early stage developmental biopharmaceutical company…with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.
Where it is located:
100 Cumming Center
Suite 151-B
Beverly, MA
1915
United States
Key Executive Contact:
Leo Ehrlich
CFO, Interim CEO
Ninety Day Volume:
257117 (as of date of publication)
Ninety Day Dollar Volume:
$475,152
Share Information:
111687129 shares as of 2014-09-05
Corporate Information:
State Incorporated: NV
Country Incorporated: USA
Contact, Website and Social Media for Cellceutix Corp.:
Shown Where Available
Website: http://www.cellceutix.com
Facebook:
Twitter:
LinkedIn:
Telephone: (978)-633-3623
Email: [email protected]
Investor Relations for Cellceutix Corp.:
E Unum Pluribus LLC
877-997-4747